A new paradigm of microbial strain development has been achieved that overcomes todayâ€™s slow, iterative and error-prone process through the use of a novel, streamlined, high throughput platform. The P. fluorescens expression platform, PfÄ“nex Expression Technologyâ„¢, reliably delivers host strains expressing large amounts of high quality target protein within very short development times. In this webcast, Dr. Charles H. Squires, Head of Discovery R&D at PfÄ“nex Inc., discusses:
â€¢ An Overview of PfÄ“nex Expression Technologyâ„¢
â€¢ How PfÄ“nex Inc. Practices the Technology
â€¢ Case Studies Highlighting the Power of the Technology
â€¢ Product Areas
â€¢ Further Uses of PfÄ“nex Expression Technologyâ„¢in Development
Join Dr. Squires as he illustrates how the combination of technologies available through the PfÄ“nex Expression Technologyâ„¢system make it the most complete, flexible and productive bacterial strain development and biopharmaceutical production platform available today.